Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Fierce Pharma
Novo’s Catalent plant ditched in FDA refiling of SMA drug
A recent FDA inspection of Novo's troubled Catalent site in Indiana has been classified as “Official Action Indicated.”
Angus Liu
Aug 10, 2026 10:06am
Novo and Amazon sign drug discovery pact, launch innovation hub
Aug 10, 2026 8:00am
Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
Aug 7, 2026 9:08am
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
Aug 7, 2026 8:42am
Novo CEO accepts ‘couple of setbacks,’ hunts for bolt-on deals
Aug 5, 2026 8:00am
Novo left praying to Artemis and Hermes as CKD trial flops
Jul 31, 2026 8:57am
